Relationship of platelet-derived growth factor with benign prostatic hyperplasia
Chu, J.; Zhong, H.-X.
Zhonghua Nan Ke Xue 13(10): 932-935
2007
ISSN/ISBN: 1009-3591 PMID: 17977330 Document Number: 612835
Benign prostatic hyperplasia (BPH) and prostatitis are very common diseases in elderly men. The recent researches demonstrate that chronic inflammation is often present in the prostatic tissue of patients with BPH and the platelet-derived growth factor (PDGF) plays an important part in stimulating prostatic cell proliferation by inducing mitogenesis. This article presents a detailed discussion on the relationship between PDGF and BPH.
Document emailed within 1 workday
Related Documents
Maygarden, S.J.; Strom, S.; Ware, J.L. 1992: Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia Archives of Pathology and Laboratory Medicine 116(3): 269-273Andresen, J.L.; Ehlers, N. 1998: Chemotaxis of human keratocytes is increased by platelet-derived growth factor-BB, epidermal growth factor, transforming growth factor-alpha, acidic fibroblast growth factor, insulin-like growth factor-I, and transforming growth factor-beta Current Eye Research 17(1): 79-87
Rizzino, A.; Kazakoff, P.; Ruff, E.; Kuszynski, C.; Nebelsick, J. 1988: Regulatory effects of cell density on the binding of transforming growth factor beta, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor Cancer Research 48(15): 4266-4271
Shimokado, K.; Tsukada, T.; Numano, F. 1988: Platelet-derived growth factor and mechanism of cell proliferation of arterial smooth muscle: macrophage-derived growth factor and arteriosclerosis Nihon Rinsho. Japanese Journal of Clinical Medicine 46(3): 600-607
Ionescu, C.; Berindan-Neagoe, I.; Burz, C.; Balacescu, O.; Balacescu, L.; Tudoran, O.; Asztalos, R.; Irimie, A. 2011: The clinical implications of platelet derived growth factor B, vascular endothelial growth factor and basic fibroblast growth factor in colorectal cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 16(2): 274-276
Kara, I.Oguz.; Sahin, B.; Gunesacar, R.; Unsal, C. 2006: Clinical significance of hepatocyte growth factor, platelet-derived growth factor-AB, and transforming growth factor-alpha in bone marrow and peripheral blood of patients with multiple myeloma Advances in Therapy 23(4): 635-645
Graves, D.T.; Owen, A.J.; Antoniades, H.N. 1983: Evidence that a human osteosarcoma cell line which secretes a mitogen similar to platelet-derived growth factor requires growth factors present in platelet-poor plasma Cancer Research 43(1): 83-87
Slomiany, B.L.; Liu, J.; Yao, P.; Piotrowski, J.; Grabska, M.; Slomiany, A. 1992: Effect of GM1-ganglioside on gastric mucosal epidermal growth factor and platelet-derived growth factor receptor expression Biochemistry International 27(1): 97-104
Lindner, V. 1995: Role of basic fibroblast growth factor and platelet-derived growth factor (B-chain) in neointima formation after arterial injury Zeitschrift für Kardiologie 84(Suppl 4): 137-144
Al-Dossari, G.A.; Jessurun, J.; Bolman, R.M.; Kshettry, V.R.; King, M.B.; Murray, J.J.; Hertz, M.I. 1995: Pathogenesis of obliterative bronchiolitis. Possible roles of platelet-derived growth factor and basic fibroblast growth factor Transplantation 59(1): 143-145
Sarkissian, M.; Lafyatis, R. 1998: Transforming growth factor-beta and platelet derived growth factor regulation of fibrillar fibronectin matrix formation by synovial fibroblasts Journal of Rheumatology 25(4): 613-622
Jonas, U.; Melchior, H.; Rübben, H. 1998: Recommendations for billing alternative therapy of benign prostatic hyperplasia. Laser therapy of benign prostatic hyperplasia Der Urologe. Ausg. a 37(1): 110-111
Westermark, B. 1995: Platelet-derived growth factor. a growth factor of great physiopathological importance Lakartidningen 92(23): 2397-2401
Kenagy, R.D.; Hart, C.E.; Stetler-Stevenson, W.G.; Clowes, A.W. 1997: Primate smooth muscle cell migration from aortic explants is mediated by endogenous platelet-derived growth factor and basic fibroblast growth factor acting through matrix metalloproteinases 2 and 9 Circulation 96(10): 3555-3560
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103
Gope, R. 2002: The effect of epidermal growth factor and platelet-derived growth factors on wound healing process Indian Journal of Medical Research 116: 201-206
Syms, A.J.; Norris, J.S.; Smith, R.G. 1984: Autocrine regulation of growth: I. Glucocorticoid inhibition is overcome by exogenous platelet derived growth factor Biochemical and Biophysical Research Communications 122(1): 68-74
Ishioka, S.; Saito, T.; Hiyama, K.; Haruta, Y.; Maeda, A.; Hozawa, S.; Inamizu, T.; Yamakido, M. 1996: Increased expression of tumor necrosis factor-alpha, interleukin-6, platelet-derived growth factor-B and granulocyte-macrophage colony-stimulating factor mRNA in cells of bronchoalveolar lavage fluids from patients with sarcoidosis Sarcoidosis Vasculitis and Diffuse Lung Diseases: Official Journal of Wasog 13(2): 139-145
Yokote, K.; Mori, S. 2005: Platelet derived growth factor (PDGF) Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 8): 103-106
Kaji, K. 1990: Assay of platelet-derived growth factor Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 122-125